For example, a study analyzing AKT and MYC dysregulation in human normal and PCa samples revealed that dysregulation of AKT1 and MYC alters non-glucose-mediated pathways and their downstream targets [136]. This evidence concerns the gene MYC and posterior cortical atrophy.